Experimental Obesity Drug Eloralintide Shows Over 11% Weight Loss in Phase I Trial Dr. Kamal Kant Kohli20 Jun 2025 9:00 AM ISTIt has been found in a phase I study that patients taking Eli Lilly's investigational obesity drug eloralintide lost more than 11% of their body...
High Rates of Cognitive Impairment in Type 2 Diabetes Linked to Age, HbA1c, and Vascular Risks: Meta-Analysis Medha Baranwal20 Jun 2025 8:00 AM ISTChina: A new systematic review and meta-analysis published in Frontiers in Endocrinology has shed light on the factors that increase the risk of mild...
Modified DASH Diet Lowers Blood Pressure via Sodium Reduction: DASH4D Trial Dr Riya Dave20 Jun 2025 8:00 AM ISTResearchers have found in a crossover feeding study (DASH4D trial) in patients with type 2 diabetes and hypertension that a low-sodium DASH4D diet...
Bronchiolitis, monoclonal antibody halves hospitalizations of children younger than six months old: Study Dr. Kamal Kant Kohli19 Jun 2025 10:15 PM ISTA single dose of the long-acting antibody nirsevimab developed to prevent respiratory syncytial virus infections (The drug has been approved at the...
Smoking leaves lasting mark on teeth, research reveals Dr. Kamal Kant Kohli19 Jun 2025 10:00 PM ISTEvidence of the permanent impact of smoking on people's teeth has been uncovered by researchers for the first time. Researchers from Northumbria...
Study Identifies D-Dimer Dynamics as Independent Predictor of AKI Patient Survival Medha Baranwal19 Jun 2025 9:15 PM ISTChina: A recent study published in Frontiers in Medicine by Dr. Lixiang Rao and colleagues from the Division of Nephrology at Liyuan Hospital, Tongji...
For patients with multiple cancers, colorectal cancer diagnosis could be lifesaving-or life-threatening: Study Dr. Kamal Kant Kohli19 Jun 2025 9:15 PM ISTA new study using one of the world's largest cancer registries shows that patient outcomes can be significantly impacted depending on when colorectal...
Smart contact lens keeps an eye on your eyes-even when they're closed: Study Dr. Kamal Kant Kohli19 Jun 2025 9:00 PM ISTA new kind of smart contact lens is poised to revolutionize how we monitor eye health. Designed to work even when the eyes are closed, this...
FDA Approves First Twice-Yearly Injectable PrEP for HIV Prevention Dr. Kamal Kant Kohli19 Jun 2025 9:00 PM ISTThe US Food and Drug Administration has approved lenacapavir (Yeztugo), the first twice-yearly injectable HIV-1 prevention option. As a capsid...
No increased risk of gynecological cancer with testosterone use after five years: Study Dr. Kamal Kant Kohli19 Jun 2025 8:45 PM ISTTransmasculine and gender-diverse individuals who use testosterone are not at increased risk of gynecological cancer in the first years of hormone...
Antidepressant withdrawal symptoms more common among long-term users, reveals study Dr. Kamal Kant Kohli19 Jun 2025 8:30 PM ISTPeople who have been taking antidepressants for more than two years are substantially more likely to experience withdrawal symptoms compared to...
Atacicept Significantly Reduces Proteinuria in IgA Nephropathy: Phase 3 Trial Results Dr. Kamal Kant Kohli19 Jun 2025 8:30 PM ISTResearchers have found in phase 3 ORIGIN 3 trial that investigational dual BAFF/APRIL inhibitor atacicept significantly reduced proteinuria in...
